ArticleInternal medicine (Tokyo, Japan)2022
Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure.
Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 9 citations in OpenAlex.
- Transthoracic echocardiography measurement versus balloon occlusive diameter for atrial septal defect: experience from a Vietnamese cohort (Vietnamese cohort: TTE vs balloon ASD sizing).Cardiovascular intervention and therapeutics · 2026Article
- Efficacy and safety of transseptal puncture-assisted atrial fibrillation ablation in patients with atrial septal occluder devices: an updated systematic review and meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Review
- Clinical importance of heart disease screening in school for detecting atrial septal defects with significant shunt.Heart and vessels · 2026Article
- Cardiac Computed Tomography in Structural Heart Interventions: From Preprocedural Planning to Procedural Strategy.Reviews in cardiovascular medicine · 2025Review
- From Catheter Complication to Surgical Success: Urgent Retrieval of an Embolized Amplatzer Device and Valve Repair.Reports (MDPI) · 2025Article
- Trans-thoracic echocardiographic findings after the closure of ostium secundum atrial septal defect: A six-month follow-up study.Journal of cardiovascular and thoracic research · 2025Article
- Paradoxical Infarction? Inferior STEMI With Unexpected Discovery of ASD in an Oncology Patient: A Case of Combined Percutaneous Intervention.Clinical case reports · 2024Article
- Effects of percutaneous closure of atrial septal defects via the right internal jugular vein.Cardiovascular diagnosis and therapy · 2024Article
- Left Atrial Stiffness Increases after Trans-Catheter Atrial Septal Closure.Journal of clinical medicine · 2024Article
- Transcatheter Closure of an Atrial Septal Defect.Internal medicine (Tokyo, Japan) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial septal defects (ASDs) are one of the most common congenital heart disorders encountered by cardiologists. Percutaneous ASD closure for secundum ASD is commonly performed not only for children but also for adults, given its non-inferiority to surgical repair. The choice of closure technique should be based on assessing a patient's baseline comorbidities, including the presence of pulmonary hypertension, supraventricular tachycardias, and left ventricular diastolic dysfunction. Furthermore, anatomical features and defect types determined using echocardiography need to be considered when developing a management plan. Percutaneous closure is often the preferred method, given its comparable successful rate to surgical repair while also being far less invasive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.